Biosynthetic binding protein for cancer marker

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/13 (2006.01) C07K 16/46 (2006.01) C12N 5/10 (2006.01) C12N 15/62 (2006.01) C12N 15/66 (2006.01)

Patent

CA 2372813

Disclosed is a single-chain Fv (sFv) polypeptide defining a binding site which exhibits the immunological binding properties of an immunoglobulin molecule which binds c-erbB-2 or a c-erbB-2-related tumor antigen, the sFv includes at least two polypeptide domains connected by a polypeptide linker spanning the distance between the C-terminus of one domain and the N-terminus of the other, the amino acid sequence of each of the polypeptide domains includes a set of complementarity determining regions (CDRs) interposed between a set of framework regions (FRs), the CDRs conferring immunological binding to the c-erbB-2 or c-erbB-2-related tumor antigen.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Biosynthetic binding protein for cancer marker does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biosynthetic binding protein for cancer marker, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biosynthetic binding protein for cancer marker will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1461237

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.